Lincoln Pharmaceuticals has informed that Meeting of the Board of Directors is scheduled to be held on May 22, 2025 to consider and approve Audited Financial Results of the Company and recommendation of Dividend on equity shares of the Company if any.
The above information is a part of company’s filings submitted to BSE.